CTRI/2018/04/013094尚未招募未知
Safety and clinical effectiveness of Alteplase in acute ischemic stroke: An observational study in a tertiary care hospital.
Department of Pharmacolog0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •patients aged 18 to 80 years diagnosed with acute ischemic stroke and who has been administered Alteplase would be included.
排除标准
- •Those who are contraindicated for thrombolysis.
研究者
相似试验
进行中（未招募）
不适用
A placebo controlled trial of alteplase (rt-PA) in acute ischemichemispheric stroke where thrombolysis is initiated between 3 and 4hours 30 minutes after stroke onset - ECASS IIIAcute ischemic hemispheric strokeEUCTR2005-003176-38-CZBoehringer Ingelheim France800
进行中（未招募）
1 期
A placebo controlled trial of alteplase (rt-PA) in acute ischemic hemispheric stroke where thrombolysis is initiated between 3 and 4 hours 30 minutes after stroke onset - ECASS IIIAcute ischemic hemispheric strokeEUCTR2005-003176-38-SKBoehringer Ingelheim France800
进行中（未招募）
不适用
A placebo controlled trial of alteplase (rt-PA) in acute ischemic hemispheric stroke where thrombolysis is initiated between 3 and 4 hours 30 minutes after stroke onset - ECASS IIIIschemic stroke 3 and 4 hours 30 minutes before treatmentEUCTR2005-003176-38-HUBoehringer Ingelheim Pharma Ges mbH800
已完成
1 期
Clinical studies on the safety and efficacy of platelet rich plasma used in anterior cruciate ligament reconstructiorupture of anterior cruciate ligamentJPRN-UMIN000014694niversity of tsukuba Department of Orthopaedic Surgery5
进行中（未招募）
不适用
A randomized controlled trial of alteplase (rt-PA) vs standard treatment in acute ischemic hemispheric stroke in patients aged more than 80 years where thrombolysis is initiated within 3 hours after stroke onset - NDacute ischemic strokeMedDRA version: 9.1Level: LLTClassification code 10043647Term: Thrombotic strokeEUCTR2007-006177-88-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA